Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[The liver-cell specific drug delivery system]

M Goto1

  • 1Kanagawa Academy of Science and Technology.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|August 1, 1994
PubMed
Summary

Targeting liver diseases requires specific drug delivery to liver cells. Researchers are coupling drugs to ligands on carriers like polymers and liposomes for effective liver-cell targeting, overcoming side effects.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A novel orally active inhibitor of IL-1 generation: synthesis and structure-activity relationships of 3-(4-hydroxy-1-naphthalenyl)-2-propenoic acid derivatives.

Journal of medicinal chemistry·1992
Same author

Atrial contractility affects phasic blood flow velocity of atrial small vessels in the dog.

Cardiovascular research·1992
Same author

Early metabolic effects of sepsis in the preterm infant: lactic acidosis and increased glucose requirement.

The Journal of pediatrics·1992
Same author

Isolation of kinesin from rat liver.

Gastroenterologia Japonica·1992
Same author

Regulation of differentiation and proliferation of rat hepatocytes by lactose-carrying polystyrene.

Artificial organs·1992
Same author

In vitro susceptibility of clinical isolates of Bacteroides fragilis and Bacteroides thetaiotaomicron in Japan.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·1992

Area of Science:

  • Biomedical Engineering
  • Drug Delivery Systems
  • Hepatology

Context:

  • Liver diseases pose significant health challenges, often inadequately addressed by conventional systemic drug administration due to off-target effects and toxicity.
  • Nonspecific drug delivery leads to limited therapeutic efficacy and increased adverse events, necessitating targeted approaches.
  • Recent advancements focus on enhancing drug delivery precision to mitigate these challenges.

Purpose:

  • To explore and summarize strategies for achieving liver-cell specific drug delivery.
  • To highlight the use of ligand-conjugated carrier systems for targeted therapeutic interventions in the liver.
  • To review the application of specific ligands and carriers for hepatocyte and non-parenchymal cell targeting.

Summary:

  • Liver-cell specific drug delivery is achieved by conjugating therapeutic agents to ligands on various carrier systems, including polymers, liposomes, and proteins.
  • Ligands such as saccharides, low-density lipoprotein (LDL), and bile acids are utilized to ensure targeted binding to liver cells.
  • These targeted carriers act as shuttles, delivering drugs specifically to hepatocytes and non-parenchymal liver cells, thereby improving treatment outcomes.

Impact:

  • This approach promises to enhance the efficacy of liver disease treatments by concentrating therapeutic agents at the target site.
  • Minimizing drug exposure to non-target organs is expected to significantly reduce systemic side effects and improve patient safety.
  • The development of targeted liver-cell drug delivery systems offers a pathway to more effective and safer pharmacological interventions for liver pathologies.

Related Experiment Videos